The IVF Shock — One Donor’s Hidden Cancer Gene May Affect 200 Children!

In one of the most worrying fertility stories in recent years, an international investigation has revealed that nearly 200 children across Europe were conceived using sperm from a donor who unknowingly carried a rare cancer-linked genetic mutation. The discovery has raised serious questions about IVF safety, donor screening, and genetic testing in fertility treatments.

How Did This Happen?

Between 2006 and 2022, a Danish man who was healthy and unaware of any serious health condition donated sperm through the European Sperm Bank (ESB) in Copenhagen. His donations were widely used at fertility clinics in 14 countries across Europe.

At the time he became a donor, he passed the standard medical and health checks. However, routine screening tests did not detect a rare genetic mutation in some of his sperm. That mutation affects a gene known as TP53, which plays a key role in preventing cancer by stopping damaged cells from multiplying.

Later scientific investigation found that up to 20% of his sperm contained this damaging mutation. When children were conceived from those sperm cells, they inherited the mutation in every cell of their bodies, giving them a very high risk of developing cancer at some point in their lives.

You may also like to read:

India’s ‘Complete Food – Milk’ Could Be a Silent Health Problem — Here’s Why!

She Didn’t Need a Husband to Become a Mom — Bhojpuri Singer Devi’s Bold IVF Journey

Indian Mom Reveals South Korea Gave Her ₹1.26 Lakh Just for Having a Baby

What Is the Risk?

The specific mutation found in this donor is linked to Li-Fraumeni syndrome, a rare genetic condition that dramatically increases a person’s lifetime risk of developing cancer up to 90% by age 60.

This means children who inherited the mutation face a much higher chance of developing cancers such as Leukaemia, Brain tumors, Bone and soft-tissue cancers and Breast cancer later in life. These are common concerns with Li-Fraumeni syndrome

Doctors report that some of the children conceived with this donor’s sperm have already developed cancer, and a few have sadly died at a young age.

Why Wasn’t It Detected Earlier?

The donor himself is healthy and has no known history of cancer, and this was because the rare mutation was present only in a portion of his sperm, not in most of his body tissues. As a result, standard genetic screening at the time did not pick it up.

According to the sperm bank, the TP53 mutation was not part of routine donor testing, and even today, such rare mutations can be very difficult to catch without extensive genetic sequencing.

The first case came to light when a child conceived from this donor was diagnosed with cancer. The fertility clinics and authorities began investigating. It took time to trace and confirm that dozens of children carried the same gene mutation.

In many European countries, there are limits on how many families one donor’s sperm can be used for, but these rules are often not coordinated across borders. As a result, one donor’s sperm was used far more widely than intended.

Experts Call for Change

Medical experts and geneticists say this case should be a wake-up call for the fertility industry. Possible changes should be included in the process.

More comprehensive genetic screening for donors, including advanced DNA analysis.

Stricter international rules on how many children a single donor’s DNA can be used for.

Improved tracking systems to ensure donor offspring can be contacted if new health risks are discovered.

Better education and counselling for prospective parents using donor materials.

IVF and donor-based fertility treatments have brought joy to millions of families worldwide, but this incident shows that even trusted systems can have blind spots. The hope is that lessons from this shocking discovery will lead to safer practices and stronger protections for future generations.

Because when it comes to bringing life into the world, every possible safeguard matters.